MORRIS PLAINS, N.J., Sept. 13, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at the 2012 UBS Global Life Sciences Conference on Thursday, September 20th at 3:30 p.m. Eastern Time at The Grand Hyatt Hotel in New York City. The presentation, which provides a corporate overview, can be downloaded simultaneously at www.immunomedics.com/pdfs/company-presentation.pdf.
